Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat and SOCS box protein 5 (ASB5) is a human protein that belongs to the ankyrin repeat and SOCS box-containing (ASB) family. These proteins contain an N-terminal ankyrin repeat domain for substrate recognition and a C-terminal SOCS box for assembly with Elongin B/C, Cul5, and Rbx2, forming part of Cullin–RING E3 ubiquitin ligase complexes. ASB proteins act as substrate-adaptor components, mediating the ubiquitination and subsequent proteasomal degradation of specific targets, thereby influencing diverse cellular processes such as protein turnover, signal transduction, and possibly vascular development. The specific substrates and physiological roles of ASB5 remain under investigation, but it is categorized structurally and functionally with other ASB family proteins that regulate key pathways in cell biology and disease.
Inhibition or modulation of substrate recognition and ubiquitination activity (disrupts recruitment of ubiquitin E2 enzymes and substrate interaction)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat and SOCS box protein 5 (ASB5).